Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis

Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis

Abstract Background Statin may confer anticancer effect. However, the association between statin and risk of hepatocellular carcinoma (HCC) in patients with hepatitis B virus (HBV) or hepatitis C (HCV) virus infection remains inconsistent according to results of previous studies. A meta-analysis was...

Full description

Bibliographic Details
Main Authors: Xiaofei Li, Lina Sheng, Liwen Liu, Yongtao Hu, Yongxin Chen, Lianqing Lou
Format: Article
Language:English
Published: BMC 2020-04-01
Series:BMC Gastroenterology
Subjects:
Statin
Hepatocellular carcinoma
Hepatitis B virus
Hepatitis C virus
Cirrhosis
Meta-analysis
Online Access:http://link.springer.com/article/10.1186/s12876-020-01222-1

Internet

http://link.springer.com/article/10.1186/s12876-020-01222-1

Similar Items